The annual price of monoclonal antibody therapies used in oncology and hematology is about $100,000 higher than those used in other disease states.
Collin G. Wolf, BS
Advertisement
Articles by Collin G. Wolf, BS
Advertisement
Latest Updated Articles
- Pricing of Monoclonal Antibody Therapies: Higher If Used for Cancer?
February 14th 2018
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About the FDA's Peptide Reversal
2
Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial
3
FDA Approves First Orexin Agonist for Narcolepsy Type 1
4
Ochsner Health, Paradigm Health Partnership Expands Clinical Trial Access Across the Gulf South
5